RENGA, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 2.493
EU - Europa 1.879
AS - Asia 741
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.120
Nazione #
US - Stati Uniti d'America 2.474
IE - Irlanda 485
UA - Ucraina 370
SE - Svezia 254
IT - Italia 242
SG - Singapore 238
VN - Vietnam 156
HK - Hong Kong 154
FI - Finlandia 135
CN - Cina 111
DE - Germania 110
RU - Federazione Russa 99
FR - Francia 61
TR - Turchia 43
GB - Regno Unito 37
KR - Corea 26
CH - Svizzera 22
CA - Canada 16
CZ - Repubblica Ceca 15
RO - Romania 13
BE - Belgio 9
PL - Polonia 8
GR - Grecia 7
NL - Olanda 6
LB - Libano 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
MX - Messico 3
UZ - Uzbekistan 3
AU - Australia 2
BR - Brasile 2
EU - Europa 2
CL - Cile 1
ES - Italia 1
HU - Ungheria 1
IN - India 1
Totale 5.120
Città #
Chandler 552
Dublin 484
San Mateo 254
Singapore 172
Jacksonville 167
Boardman 160
Dong Ket 156
Hong Kong 154
Altamura 140
Medford 119
Princeton 119
Lawrence 101
Andover 98
Wilmington 96
Ann Arbor 86
Perugia 57
Beijing 49
Des Moines 42
Izmir 42
Saint Petersburg 37
Ashburn 35
Helsinki 21
Falls Church 16
Norwalk 16
Seoul 15
San Paolo di Civitate 13
Timisoara 13
Woodbridge 13
Dearborn 12
New York 12
Ottawa 12
Los Angeles 11
Olomouc 11
Santa Clara 10
Brussels 9
Munich 8
Auburn Hills 6
Shanghai 6
Den Haag 5
Lausanne 5
Moscow 5
Al Ain City 4
Houston 4
Redwood City 4
Dallas 3
Frankfurt Am Main 3
London 3
San Diego 3
Simi Valley 3
Toronto 3
Lappeenranta 2
Nanjing 2
Phoenix 2
Rovato 2
Stenico 2
Sydney 2
São Paulo 2
Tappahannock 2
Alameda 1
Alba 1
Amsterdam 1
Atatürk 1
Atlanta 1
Bisaccia 1
Bologna 1
Budapest 1
Cangzhou 1
Chennai 1
Chongqing 1
Cork 1
Deruta 1
Edinburgh 1
Foggia 1
Foligno 1
Fremont 1
Hanover 1
Hefei 1
Kiev 1
Kunming 1
Ludwigshafen 1
Miami 1
Moline 1
Montreal 1
Napoli 1
Pasadena 1
Philadelphia 1
Piacenza 1
Prague 1
Redmond 1
Rome 1
Salerno 1
San Jose 1
Seattle 1
Shenyang 1
Tolentino 1
Turin 1
Vico Equense 1
Weihai 1
Wuxi 1
Totale 3.426
Nome #
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 87
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 86
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 85
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 84
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 76
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 72
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 72
Antiatherosclerotic effect of farnesoid X receptor. 71
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 68
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 68
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 67
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 67
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 65
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 64
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 64
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 63
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 62
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 62
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 61
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 61
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 61
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 58
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 57
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 56
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 56
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 55
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 55
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 55
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 55
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 54
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 54
Role of the FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases 53
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 53
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 53
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 53
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 52
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 52
The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. 51
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 51
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 51
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. 50
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 50
The third gas: H2S regulates perfusion pressure in both theisolated and perfused normal rat liver and in cirrhosis. 50
Il valore predittivo del polimorfismo C-1237T del toll-like receptor 9 nell’eruzione eritemato-papulo-pustolosa da inibitori del fattore di crescita epidermico 47
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 47
Critical role of toll-like receptors in modulating GM-CSF activity in rodent models of colitis 47
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 47
Structural insights into Estrogen Related Receptor-β modulation: 4-methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. 47
FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. 47
Nitric oxide (NO)-releasing naproxen (HCT-3012) interactions with aspirin in gastric mucosa of arthritic rats reveals a role for aspirin-triggered lipoxin, prostaglandins and NO in gastric protection. 46
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 45
The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes. 44
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. 44
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 44
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 44
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands. 44
Gene Expression Changes Induced by HIPEC in a Murine Model of Gastric Cancer 44
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 44
Modification in the side chain of solomonsterol A: discovery of cholestan disulfate as a potent pregnane-X-receptor agonist 44
The methyl trasnferase PRMT1 functions as coactivator of FXR/RXR and regulates transcription of FXR responsive genein hepatocytes 42
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 42
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 42
The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. 41
Polyhydroxylated sterols from the Indonesian softcoral Sinularia sp. and their effect on farnesoid X-activated receptor. 41
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 41
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 41
The bile acid receptor FXR is a modulator of intestinal innate immunity. 41
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 41
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. 40
Pregnane-X-receptor mediates the anti-inflammatoryactivities of rifaximin on detoxification pathways in intestinal epithelialcells. 40
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 40
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 40
Farnesoid-X-receptor (FXR) ligands induce a small heterodimer partner (SHP)-dependent upregulation of PPAR-gamma in hepatic stellate cells and in rat model of liver fibrosis. 39
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 38
Inhibition of hydrogen sulfide generation contributes to gastric injury caused byanti-inflammatory nonsteroidal drugs. 38
Il valore predittivo del polimorfismo C1237-T di TLR9 mutato nell’eruzione eritemato-papulo-pustolosa da inibitori dei recettori del fattore di crescita epidermico 37
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 36
Co-administration of nitric oxide-aspirin (NCX-4016) andaspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. 34
Protective effects of granulocyte macrophage colony stimulating factor (gm-Csf) in Hapten-induced colitis 34
Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges. 34
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 34
Theonellasterols and conicasterols fromTheonella swinhoei. Novel marine natural ligands for human nuclear receptors. 33
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 33
Solomonsterols A and B from Theonella swinhoei. The First Example of C-24 and C-23 Sulfated Sterols from a Marine Source Endowed with a PXR Agonistic Activity. 33
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 33
HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes 33
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 33
Role of Nuclear Receptors in Lipid Dysfunction and Obesity-related Diseases. 32
‘The Farnesoid X Receptor Promotes Adipocyte Differentiationd regulates adipose cell function in vivo’ 31
Molecular Determinants of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Model of Peritoneal Gastric Cancer Carcinogenesis 31
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 31
Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. 31
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 31
Quantitative NMR-Derived Interproton Distances Combined with QuantumMechanical Calculations of (13)C Chemical Shifts in the StereochemicalDetermination of Conicasterol F, a Nuclear Receptor Ligand from Theonellaswinhoei. 31
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 30
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 30
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 29
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 29
The bile acid sensor FXR regulates insulin transcription and secretion. 29
Enhanced anti-inflammatory activity of hydrogen sulfide releasing derivative of mesalamine in rodent models of colitis, involves direct inhibition of Nf-kappa B 28
Totale 4.812
Categoria #
all - tutte 24.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020302 0 0 0 0 53 28 72 16 79 36 4 14
2020/2021917 4 69 43 83 281 47 51 3 72 27 62 175
2021/2022898 14 167 9 48 31 10 10 342 6 13 92 156
2022/20231.798 129 344 11 175 135 188 0 89 662 2 47 16
2023/2024600 42 78 46 6 4 4 140 26 36 20 126 72
2024/2025294 17 144 61 46 26 0 0 0 0 0 0 0
Totale 5.296